Menu

Zika’s Effects on Babies Can Show Up Later

The CDC finds one in seven children exposed to the virus in utero experiences health problems by age one.

Aug 7, 2018
Kerry Grens

ABOVE: © ISTOCK, AYWAN88

Around 14 percent of babies whose mothers contracted Zika while pregnant ended up with a birth defect, developmental abnormality, or both, according a report released by the US government today (August 7). Some of the symptoms didn’t show up right away when the babies were born, but emerged in later testing.

“The full range of long-term health problems caused by Zika will remain unknown until these babies mature,” according to a summary of the report from the Centers for Disease Control and Prevention (CDC).

The agency collected health data on 1,450 babies at least one year old who were exposed to Zika in utero and born in a US territory. Six percent of the children had a Zika-associated birth defect, but others’ symptoms showed up later in life. Among 822 babies who did not have a birth defect, 14 had a brain abnormality that was revealed in neuroimaging.

See “Mouse Pups Infected With Zika Show Symptoms Into Adulthood

“That happened because their brain was not growing and developing properly” due to the virus, Margaret Honein, director of the Division of Congenital and Developmental Disorders at the CDC, tells NPR.

In the US and its territories, reports of Zika infections tapered off at the beginning of 2017, with very few cases popping up since then. However, this likely isn’t the end of Zika, and outbreaks may re-emerge.

“I think the bottom line is that the Zika story is not over,” Honein tells The Washington Post. “People may feel like it’s behind us. For these children, it’s not over, and we need to know as much as possible so that we can be prepared” for a future outbreak.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.